A PAK6–IQGAP1 complex promotes disassembly of cell–cell adhesions by Sally Fram et al.
1 3
DOI 10.1007/s00018-013-1528-5 Cellular and Molecular Life Sciences
Cell. Mol. Life Sci. (2014) 71:2759–2773
ReSeaRCh aRtICLe
A PAK6–IQGAP1 complex promotes disassembly of cell–cell 
adhesions
Sally Fram · Helen King · David B. Sacks · 
Claire M. Wells 
Received: 18 april 2013 / Revised: 30 October 2013 / accepted: 18 November 2013 / Published online: 19 December 2013 
© the author(s) 2013. this article is published with open access at Springerlink.com
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Introduction
epithelial-to-mesenchymal transition (eMt) is a develop-
mental process that involves the loss of cell–cell junction 
integrity, cell–cell dissociation, and ultimately leads to the 
emergence of independently migratory cells [42]. Cell scat-
tering has also been observed in some cancer cell popula-
tions where cells that have undergone an eMt-like process 
and are able to disseminate to distal sites [51]. hepato-
cyte growth factor (hGF) is well known to elicit such a 
cell scattering response in a number of different cell lines, 
including prostate carcinoma DU145 cells [46].
In normal tissue, epithelial cells are held together by a 
plethora of cell–cell adhesion molecules focused around a 
number of different junctional complexes including tight 
junctions, desmosomes, and adherens junctions. During 
both normal and carcinoma development the initial stages 
of cell–cell dissociation requires the disassembly of these 
junctions between neighboring cells. e-cadherin is a major 
component of adherens junctions and loss of e-cadherin 
expression is often associated with cell–cell dissociation 
and cancer progression [8]. the homotypic interactions 
of e-cadherin extracellular domains are complemented by 
the intracellular domain of e-cadherin binding a number of 
cytoplasmic partners, including the catenin family of pro-
teins, which ultimately lead to a link between e-cadherin 
and the actin cytoskeleton [15]. Junctional disruption is 
associated with a re-organization of the actin cytoskeleton, 
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a process thought to be mediated by the activity of Rho 
family GtPases. While much is known about how adher-
ens junctions are formed, less is known about the signal-
ing events and molecular interactions that lead to junctional 
dissociation. activation of Rac1 and Cdc42 can abolish the 
multi-cellular organization of breast carcinoma cells in a 
3D matrix [20] and disrupts cell–cell adhesions in human 
keratinocytes [4] and pancreatic carcinoma cells [13]. 
Moreover, Rac1 and Cdc42 are both known to interact with 
isoform 1 of the IQ motif containing GtPase activating 
protein (IQGaP) family of proteins [21], and a Rac-1–IQ-
GaP1 interaction is thought to mediate the dissociation of 
β-catenin from e-cadherin downstream of hGF in MDCK 
cells [10]. In addition, phosphorylation of catenin proteins 
has been correlated with junctional disruption [39]. how-
ever, the role of IQGaP1 in junctional dynamics is still not 
clearly understood.
the p-21-activated kinases (PaKs) family has been 
implicated in the regulation of both cell matrix adhesion 
and migration [49] and there is some evidence that these 
proteins might also play a role in junctional dynamics [29]. 
the family is split into two groups [49] and it has been 
shown that the Drosophila homologue of Group II PaKs 
is localized at adherens junctions and is involved in the 
cell–cell dissociation process during eye maturation [33]. 
a recent report also demonstrated that PaK4 interacts with 
β-catenin, implicating this kinase in β-catenin re-localiza-
tion and signaling [26], however this study was not con-
ducted in a colony-forming cell line so could not be cor-
related to junctional dynamics.
Recently, PaK6, a less well studied member of the PaK 
family was identified as a putative IQGaP1 binding pro-
tein [18] but the functional implications were not explored. 
Indeed, to date, very little is known about the role of PaK6 
in mammalian cells other than as an androgen receptor-inter-
acting protein [50]. Moreover, unlike other family members, 
the interaction between PaK6 and the GtP bound form of 
Cdc42 does not increase PaK6 kinase activity [38] and the 
regulatory mechanisms of PaK6 activity are not well under-
stood. PaK6 expression has been linked to prostate cancer 
invasiveness but no mechanism has been identified [48]; thus 
a functional role for PaK6 expression outside of androgen 
signaling remains to be elucidated. We have used the DU145 
cell scattering model to identify an essential role for PaK6 
during hGF-induced cell–cell dissociation. Moreover, we 
find that increased levels of PaK6 expression and activity 
can drive cell–cell dissociation and this phenotype is further 
elevated upon co-expression with IQGaP1. We have charac-
terized the interaction between IQGaP1 and PaK6 and iden-
tify IQGaP1 as a novel regulator of PaK6 kinase activity. 
Furthermore, we identify β-catenin as a PaK6 substrate and 
propose that PaK6 phosphorylation of β-catenin drives the 
disassembly of cell–cell adhesions.
Results
hGF stimulation increases PaK6 autophosphorylation
We have previously used a hGF-induced human cell scat-
tering model to elucidate the role of PaK4 in adhesion 
turnover [47]. We now report that colon carcinoma ht29 
cells (express c-Met) can also be used to monitor hGF-
induced cell scattering (Figs. S1a and S1B). Our previous 
work had utilized an antibody that recognizes both PaK4 
and PaK6 to detect PaK6 in DU145 cells [47] (hereafter 
referred to as anti-PaK4/PaK6) (Fig. S1C) we now incor-
porate the use of a PaK6-specific antibody (Calbiochem). 
Using these antibodies, we can confirm that PaK6 is 
expressed in DU145 and ht29 cell lines (Fig. S1D). Ser-
ine 560 (S560) in the PaK6 kinase domain is thought to 
be an autophosphorylation site homologous to serine 474 
(S474) in PaK4 [1]. Upon hGF stimulation in both DU145 
and ht29 cells, endogenous PaK6 S560 levels were seen 
to significantly increase (Fig. 1a, b). an increased concen-
tration of hGF was required to elicit the ht29 response 
(which was less than that seen in DU145 cells), which may 
be due to accessibility of c-Met receptor within the tightly 
packed ht29 cell colonies.
PaK6 is required for hGF-induced cell–cell dissociation
Given that PaK6 autophosphorylation is elevated down-
stream of hGF it might be speculated that PaK6 plays a 
role in the cellular response to hGF. two different siRNa 
oligonucleotides were employed to knockdown PaK6 
expression levels in DU145 cells (Figs. 1c, S1e). the level 
of PaK6 was significantly reduced when compared to 
control siRNa lysates and neither siRNa affected PaK1, 
PaK2, or PaK4 expression (Fig. 1c). DU145 cells trans-
fected with control siRNa exhibited hGF-induced cell–cell 
Fig. 1  PaK6 and hGF-induced cell scattering. a, b Serum-starved 
cells were stimulated with hGF [10 ng/ml (a) or 60 ng/ml (b)] for the 
times indicated. Lysates were immunoblotted for levels of S560 PaK6 
autophosphorylation. Blots were re-probed for total PaK6. Changes 
in PaK6 S560 levels were quantified (quantified band marked with 
asterisk) using andor IQ software. Data represents mean ± SeM. c 
DU145 cells were transfected with control (Con) or PaK6 (Oligo 1 or 
2) siRNa oligos lysed after 72 h and immunoblotted for PaK6/4/1/2 
and GaPDh as a loading control. d DU145 cells were transfected as 
shown. Following 72 h, cells were serum-starved for 24 h and stimu-
lated with hGF for 24 h. the cells were fixed and stained for F-actin, 
counted and scored for cell scattering. e DU145 cells were transfected 
with Con siRNa or Oligo 1. after 72 h, cells were serum-starved for 
24 h and stimulated with 10 ng/ml hGF for 4 or 24 h as indicated. 
the cells were then fixed and stained for e-cadherin and F-actin and 
imaged using confocal microscopy. all data are representative of 
three independent experiments where n = 90 cells per condition. Data 
represents mean ± SeM. Statistical significance was calculated using 
Student’s t test, *p < 0.05
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dissociation and subsequent cell scattering, by contrast loss 
of PaK6 expression significantly reduced the scattering 
response of both DU145 and ht29 cells to hGF (Figs. 1d, 
S2a). Closer examination of hGF-treated PaK6 siRNa 
colonies suggested that cells were not disassembling their 
cell–cell junctions, a normal hGF response (Fig. 1e). In 
control siRNa-treated cells following 4 h of hGF stimu-
lation cell–cell adhesions can be seen to dissociate and 
e-cadherin staining (a junctional marker [12]) is only 
present at adjoining cells. at 24 h after hGF stimulation, 
e-cadherin-positive staining is undetectable in the control 
cells. In contrast, the cell borders in PaK6 knockdown cell 
populations were e-cadherin positive, with distinct and 
extensive punctate staining following 4-h stimulation with 
hGF (Fig. 1e) and the cell–cell boundaries in the PaK6 
knockdown cell population were still robustly e-cadherin 
positive after 24 h of stimulation (Fig. 1e).
PaK6 kinase activity drives cell colony escape/extrusion
Given that cells with reduced PaK6 expression are unable 
to dissemble junctions in response to hGF, we wondered 
whether PaK6 might promote junction disassembly. to 
investigate the effect of PaK6 overexpression, a number 
of PaK6 derivatives were generated; full-length PaK6 
(PaK6wt), full-length kinase dead PaK6 (PaK6K436a) and 
full-length kinase activated PaK6 (PaK6S531N). all deriv-
atives were tested for binding to Cdc42 and for the level 
of kinase activity (Figs. S2B and C). It was immediately 
apparent that PaK6 overexpression induced a distinctive 
phenotype when compared to control cells (Fig. 2a, b) 
where PaK6wt-expressing cells were significantly elon-
gated and highly expressing cells become rounded. PaK6 
S531N
-expressing cells were also elongated, although not to 
the same degree as Wt PaK6-expressing cells (Fig. 2a, b), 
and highly expressing cells also become rounded. how-
ever, cells expressing PaK6K436a were not significantly dif-
ferent to control cells (Fig. 2a, b). Upon closer observation, 
it was clear that cells overexpressing PaK6 were detach-
ing from neighboring cells and were no longer contained 
within the cell colony. Moreover, PaK6S531N cells were 
being extruded from cell colonies (Fig. 2a, arrow) while 
there was no obvious dissociation of PaK6K346a cells 
(Fig. S2e). to further investigate this colony escape/extru-
sion phenomenon, expressing cells were scored based on 
whether they were present in a cell colony versus escap-
ing the cell colony (Fig. 2c). While control GFP-express-
ing cells clearly remained in colonies, the percentage of 
PaK6wt and PaK6S531N-expressing cells retained in colo-
nies was significantly reduced (Fig. 2d). In contrast, cells 
expressing PaK6K436a were found predominantly within a 
cell colony (Fig. 2d). Over-expression of PaK6wt in ht29 
cells also drove colony escape to a significant level when 
compared to GFP control cells (Fig. S2D).
PaK6 localizes to cell–cell junctions
Our data suggest that PaK6 can regulate the integrity of 
cell–cell adhesions. Due to the lack of appropriate anti-
body, we cannot detect endogenous PaK6, thus cells 
expressing a low level of PaK6wt were targeted (cells with 
high PaK6wt expression are escaping the cell colony). 
PaK6 was found to be specifically localized at cell–cell 
boundaries with punctate and distinct localization (Fig. 3a), 
which correlated with the pattern of e-cadherin localiza-
tion (Fig. 3a, arrows). the localization of PaK6S531N could 
not be determined in colony cells as PaK6S531N-expressing 
cells had already escaped from colonies, but PaK6K436a 
was diffusely localized in the cell cytoplasm and was never 
specifically detected at cell junctions (Fig. S2e).
PaK6 interacts with IQGaP1
to further explain the mechanism underlying PaK6 media-
tion of junctional integrity, we sought to identify junction-
relevant PaK6 binding partners. a previous analysis by 
mass spectrometry of protein obtained from 293-t cells 
identified IQGaP1 as a possible PaK6-interacting protein 
[18]. IQGaP1 is thought to regulate cell–cell dissociation 
downstream of hGF [10]. thus, we speculated that PaK6 
and IQGaP1 might play a synergistic role in disruption 
of cell–cell adhesions. although IQGaP1 is thought to be 
ubiquitously expressed [44], its expression in prostate can-
cer cells has not been examined. We found that IQGaP1 
was expressed in DU145 cells (Fig. 3b). Moreover, over-
expressed IQGaP1wt was detected and enriched at e-cad-
herin-positive junctions (Fig. 3c), consistent with previous 
studies in breast epithelial cells [28, 41].
Fig. 2  PaK6 overexpression induces morphological changes in 
DU145 cells. a, b DU145 cells were transfected with GFP control 
vector or GFP-PaK6 mutants as indicated. Serum-starved cells were 
stimulated with hGF (plus hGF) for 5 min. Cells were then fixed 
and stained for F-actin and imaged using confocal microscopy. Shape 
analysis was performed on the cells using ImageJ software to deter-
mine the elongation ratio. Asterisk PaK6S531N-expressing cell with 
rounded phenotype. Arrow PaK6S531N-expressing cell with elon-
gated phenotype. c Schematic illustrating cell phenotype categoriza-
tion 1 cells escaping a colony defined as greater than 50 % of the cell 
body perimeter detached from the neighboring cell(s). 2 cells already 
escaped from a colony defined as cells exhibiting 100 % dissociation 
from the neighboring cell(s) or cells in a different plane to the under-
lying cell colony. d the mean % of GFP-expressing cells present in 
colonies. Data represents 110 cells per condition over three independ-
ent experiments, mean ± SeM. Statistical significance compared with 
GFP control cells was calculated using Student’s t test, *p < 0.05, 
**p < 0.005. ***p < 0.0005, ns not significant. bar = 10 μm
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to further characterize the putative interaction between 
IQGaP1 and PaK6, a structure–function analysis was con-
ducted in heK293 cells using various full-length and domain 
mutants (Fig. 4a). here we were able to show that endog-
enous PaK6 and GFP-IQGaP1Wt are immunoprecipitated 
together (Fig. 4b). Both PaK6 and IQGaP1 are reported to 
interact with activated Cdc42 [14, 21, 24]. thus, the interac-
tion between IQGaP1 and PaK6 may be mediated through a 
joint interaction with Cdc42. Indeed, full-length IQGaP1wt, 
Cdc42v12, and full-length PaK6wt were present in a complex 
(Fig. S3a). however, we also detected IQGaP1wt bound to 
the C-terminus of PaK6 where there is no Cdc42 binding 
site (Fig. 4c), and full-length PaK6wt selectively interacted 
with the N-terminal region of IQGaP1 (Fig. 4d) outside 
the Cdc42 binding region, suggesting the interaction can be 
Cdc42 independent. Indeed using IQGaP1 N-terminal trun-
cated proteins we were able to specify that the C-terminus of 
PaK6 binds to IQGaP1717–863 (Fig. 4e). IQGaP1717–863 does 
not contain the Cdc42 binding site [14, 31], confirming that 
Cdc42 is not required. Subsequently, we were able to detect 
the interaction in DU145 cells where GSt-PaK6 bound to 
endogenous IQGaP1 (Fig. 4f).
IQGaP1 induces colony escape synergistically with PaK6
Given that IQGaP1 and PaK6 interact, the effect of 
IQGaP1wt overexpression on cells was compared to 
the morphological changes already described for PaK6 
(Fig. 2a, b). GFP-IQGaP1wt-expressing cells exhib-
ited significantly higher elongation ratios than con-
trol cells (Fig. 5a), similar to the cell shape changes 
observed for PaK6-expressing cells. Moreover, when 
GFP-IQGaP1wt was co-expressed with RFP-PaK6wt the 
phenotype was further enhanced (Fig. 5a, b). Moreover, 
Fig. 3  PaK6 and IQGaP1 
at cell–cell junctions. a, c 
DU145 cells were trans-
fected with GFP-PaK6wt or 
IQGaP1-GFPwt. Serum-starved 
cells were fixed and labeled 
for e-cadherin and F-actin. 
Low-level GFP-PaK6wt and 
IQGaP1-GFPwt expression 
could be detected at e-cadherin-
positive cell–cell junctions 
(arrows). b DU145 whole-cell 
lysate was immunoblotted for 
endogenous IQGaP1 and for 
eRK1/2 as a loading control. 
all data are representative of 
three independent experiments. 
bar = 10 μm
Fig. 4  a PaK6 and IQGaP1 domain interactions. a Schematic 
illustrating PaK6 and IQGaP1-generated constructs. b heK293 
cells were transfected with IQGaP1-GFPwt. Samples were immu-
noprecipitated with anti-GFP antibodies and immunoblotted for 
endogenous PaK6 and IQGaP1-GFPwt. c heK293 cells were trans-
fected with N- or C-terminal RFP-PaK6 mutants and IQGaP1-
GFPwt as indicated. Immunoprecipitated IQGaP1-GFPwt samples 
were immunoblotted using anti-GFP and anti-RFP antibodies. 
Whole-cell lysates (WCL) were immunoblotted using anti-GFP 
and anti-RFP antibodies as controls (arrows). d heK293 cells 
were transfected with N- or C- terminal Myc-IQGaP1 mutants and 
GFP-PaK6wt as indicated. Immunoprecipitated N- and C-terminal 
IQGaP1 samples were immunoblotted for GFP-PaK6wt and for 
N- and C-terminal Myc-IQGaP1. WCL were immunoblotted using 
an anti-GFP antibody as a loading control. e heK293 cells were 
transfected with C-terminal GFP-PaK6 and lysates used in a GSt 
or GSt-IQGaP1717–863 pulldown. Samples were immunoblotted 
with anti-GFP and anti-GSt antibodies. WCL were immunoblotted 
with anti-GFP antibody as a control. f GSt-PaK6 and GSt alone 
pulldowns from DU145 cell lysates were immunoblotted for endog-
enous IQGaP1 and GSt. Data are representative of three independ-
ent experiments, control = untransfected cells
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IQGaP1wt-expressing cells and cells co-expressing 
IQGaP1wt and PaK6wt were uncoupled from neighboring 
cells and were no longer within the cell colony (Fig. 5b) 
thereby replicating and enhancing the PaK6wt phenotype, 
respectively.
Peak interaction between PaK6 and IQGaP1 
following 4-h hGF stimulation
Loss of e-cadherin positive cell–cell junctions from 
DU145 cells responding to hGF occurs approximately 4 h 
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post-stimulation (Fig. 1e). a small but significant increase 
in the interaction between GSt-PaK6 and endogenous 
IQGaP1 was observed following 4-h hGF stimulation 
when compared to serum-starved conditions (Fig. 5c), 
thereby correlating with hGF-induced cell–cell disso-
ciation. Furthermore, following 8-h stimulation, the inter-
action between these two proteins was restored to near 
serum-starved levels (Fig. 5c). In PaK6 knockdown cells, 
e-cadherin is retained at cell–cell junctions downstream of 
hGF (Fig. 1e). We found that GSt-PaK6 could specifically 
pulldown e-cadherin, moreover following 4-h hGF stimu-
lation, there was a significant increase in the level of inter-
action between GSt-PaK6 and endogenous e-cadherin 
(Fig. 5d). additionally, the interaction between GSt-PaK6 
and e-cadherin diminished following 8-h hGF stimulation, 
similar to the interaction trend observed between GSt-
PaK6 and IQGaP1 (Fig. 5c). Furthermore, GSt- PaK6, 
endogenous IQGaP1, and endogenous e-cadherin were 
found in a complex together following 4-h hGF stimula-
tion (Fig. S3B).
PaK6 phosphorylation levels are elevated in the presence 
of IQGaP1
Our data points to an e-cadherin, IQGaP1, and PaK6 
complex that forms as cell–cell dissociation occurs. as 
IQGaP1 binds to the kinase region of PaK6 (Fig. 4e), it 
was hypothesized that IQGaP1 may be a PaK6 substrate. 
however, in an in vitro kinase assay, recombinant PaK6 
did not phosphorylate IQGaP1wt (Fig. 6a). Unexpect-
edly, the presence of IQGaP1wt induced an increase in the 
autophosphorylation level of PaK6 (Fig. 6a). there are no 
other detectable bands in the in vitro kinase assay so we do 
not think that another kinase/activating proteins are being 
co-immunoprecipitated with IQGaP1. although PaK6 
S560 levels were modestly increased upon early hGF 
stimulation (Fig. 1a, b), the phosphorylation levels at this 
residue were unaltered in the presence of the IQGaP1 (Fig. 
S3C), implying that IQGaP1 affects other sites. Moreover, 
S560 levels were not elevated during the peak interaction 
of IQGaP1, e-cadherin and PaK6 downstream of hGF 
(Fig. S3D), and an S560 point mutation does not elevate the 
kinase activity of PaK6 (Fig. S2C). thus, the full signifi-
cance of S560 phosphorylation remains to be elucidated.
PaK6 binds to and phosphorylates β-catenin
Given that IQGaP1 is not a PaK6 substrate, we looked for 
alternative substrates in the context of cell–cell junctions. 
IQGaP1 and e-cadherin both interact with β-catenin [5, 
22]. Moreover, PaK1 and PaK4 have been shown to phos-
phorylate β-catenin at serine 675 (S675), although this was 
associated with Wnt signaling and transcriptional activa-
tion [26, 40]. Interestingly, the Drosophila homologue of 
PaK4/PaK6 destabilizes junctions via phosphorylation of 
armadillo, a β-catenin homologue [33]. We find here that 
PaK6 can be immunoprecipitated with β-catenin from 
cell lysates (Fig. 6b). Furthermore, in an in vitro kinase 
assay, PaK6 can directly phosphorylate β-catenin (Fig. 6c, 
arrow). Importantly, PaK6 and β-catenin are both localized 
at e-cadherin-positive cell junctions (Fig. 6d). Moreover, 
in an in vitro kinase assay using recombinant proteins, the 
level of β-catenin serine 675 phosphorylation is increased 
in the presence of PaK6 (Fig. S3e). these data demon-
strate that PaK6 phosphorylates β-catenin, and allowed us 
to hypothesize that serine 675 phosphorylation might be 
linked to junctional dissociation. to further test this hypoth-
esis, we have overexpressed β-cateninwt and non-phospho-
rylatable β-cateninS675a in our cells. Interestingly, we find 
that that while overexpressed β-cateninwt is predominantly 
nuclear with some cytoplasmic localization, overexpression 
of β-cateninS675a is consistently found at the cell periphery 
in areas of cell–cell association (Fig. 7 arrow), and is often 
excluded from the nucleus, suggesting that phosphorylation 
at S675 facilitates the removal of β-catenin from junctional 
complexes. the differential localization of β-cateninwt 
compared to β-cateninS675a was further validated by per-
forming the analysis in a second colony-forming cell line 
(Fig. S4).
Discussion
Very little is known about the function of PaK6 in cells 
other than as an androgen receptor binding protein or in the 
context of neuronal cell development. We report here that 
depletion of PaK6 expression inhibits hGF-induced cell–
cell junction dissolution and subsequent cell scattering. In 
contrast, overexpression of PaK6 drives cell–cell dissemi-
nation, a process dependent on kinase activity. PaK6 was 
localized at e-cadherin-positive junctions and was found to 
interact with the junctional protein IQGaP1, with increased 
interaction downstream of hGF. thus, we propose that 
Fig. 5  IQGaP1 overexpression induces morphological changes in 
DU145 cells. a, b DU145 cells were transfected as indicated or left 
as untransfected cells (Ut). Serum-starved cells were then fixed 
and stained for F-actin. Shape analysis was performed on the cells 
using ImageJ software to determine the elongation ratio. Cells were 
then scored for presence within a colony compared to control cells 
(as described in Fig. 2). 110 cells were analyzed per condition over 
three independent experiments. c, d GSt-PaK6 or GSt was used in a 
pulldown from serum-starved or hGF (250 ng/ml) stimulated DU145 
cell lysates as indicated. Pull-down samples were immunoblot-
ted for endogenous IQGaP1 (c) or endogenous e-cadherin (d). the 
level of binding between PaK6 and IQGaP1 was quantified using 
aNDOR IQ technology software. Data represents mean ± SeM. Sta-
tistical significance was calculated using Student’s t test; *p < 0.05, 
***p < 0.0005. bar = 10 μm
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Fig. 6  IQGaP1 expression 
increases PaK6 phosphoryla-
tion levels. a GFP-IQGaP1wt 
was immunoprecipitated from 
heK293 cells and mixed 
with or without GSt-PaK6 as 
indicated. an in vitro kinase 
assay was performed using 
[γ-32P] atP. GSt-PaK6 alone 
was also subjected to the in 
vitro kinase assay and GSt 
was used as a control. WCL 
were immunoblotted using an 
anti-GFP antibody as a loading 
control. Quantification indicates 
mean fold increase in autophos-
phorylation signal between 
GSt-PaK6 alone and GSt-
PaK6 in the presence of GFP-
IQGaP1wt. b heK293 cells 
were transfected as indicated 
or left as untransfected cells 
(control) samples were immu-
noprecipitated with anti-c-Myc 
antibodies and immunoblotted 
for GFP-β-cateninwt and Myc-
PaK6wt as a loading control. 
WCL were immunoblotted for 
GFP and Myc as a control. c 
Myc-PaK6wt was immuno-
precipitated from cell lysates 
and mixed with or without Wt 
GSt- β-catenin as indicated. 
an in vitro kinase assay was 
performed using [γ-32P] atP. 
GSt- β-catenin alone was also 
subjected to the in vitro kinase 
assay. WCL were immuno-
blotted using an anti-c-Myc 
antibody as a loading control. 
d Wt RFP-PaK6-transfected 
DU145 cells were stained for 
endogenous β-catenin and 
for endogenous e-cadherin. 
bar = 10 μm. all data are rep-
resentative of three independent 
experiments, mean ± SeM
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PaK6 and IQGaP1 function synergistically downstream of 
hGF to induce cell–cell dissociation.
Cell–cell dissociation is both a normal physiological 
process during embryonic development and part of the 
pathological progression of cancer. however, while the 
molecular mechanisms that drive cell–cell adhesion forma-
tion are well characterized, the dissolution of junctions is 
less well understood. It is well established that hGF can 
induce cell–cell dissociation and that hGF signaling plays 
a role in prostate cancer metastasis [11]. We have found 
that hGF stimulation only modestly increases the level of 
S560 PaK6 autophosphorylation and S560 phosphoryla-
tion was still detected in serum-starved conditions. Recent 
evidence does suggest that the comparable serine site in 
PaK4 (S474) might be constitutively phosphorylated in 
some cells [3]. however, PaK4 S474 levels are suppressed 
by serum starvation and re-elevated by exposure to hGF in 
DU145 cells (this paper and previous work [45, 47]. PaK1, 
the most extensively studied group I PaK, is known to have 
multiple autophosphorylation sites [7]. It is possible that 
PaK6 is phosphorylated downstream of hGF on residues 
other than serine 560, which has been tested here, and thus 
these results may not reflect the complete activating poten-
tial of hGF signaling on PaK6. Indeed, we observed that 
mutating serine 560 does not increase the kinase activity of 
PaK6, but that mutating serine 531 increased PaK6 kinase 
activity (reported in previous work [38]). In addition, while 
serine 560 phosphorylation is known to be required for 
PaK6 activation via MKK6, PaK6 is also directly activated 
by MKK6 at tyrosine 566 [19]. this supports a hypothe-
sis that the phosphorylation of other residues on PaK6 is 
important for PaK6 activation.
During hGF-induced DU145 cell scattering, cells 
become more elongated, undergo cell–cell detachment, and 
subsequent cell colony escape [46]. PaK6 overexpression 
was found to induce such morphological and phenotypical 
changes in DU145 cells in the absence of hGF stimulation. 
this is in contrast to overexpression of other PaK family 
members, where PaK4 overexpression exhibited no effects 
on the morphology of MDCK cells [45] or NIh 3t3 mouse 
embryo fibroblasts [36]. Indeed, the majority of PaK-
induced cell-shape changes have been detected only when 
the constitutively active forms of PaK1, 2, or 4 were uti-
lized [30, 36, 53]. Not only did overexpression of PaK6wt 
Fig. 7  β-catenin S675a 
preferentially localizes to the 
cell periphery. DU145 cells 
were transfected with GFP-β-
cateninwt or flag-β-cateninS675e 
as indicated. Cells were fixed 
and stained for F-actin and flag 
tag as required. all data are rep-
resentative of three independent 
experiments. Arrow indicates 
the peripheral localization of 
β-cateninS675e, and the asterisk 
indicates position of expressing 
cell nucleus within the colony. 
Bar = 10 μm
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induce cell elongation, but it also drove escape from a cell 
colony in the absence of hGF stimulation. Moreover, col-
ony escape was dependent on PaK6 kinase activity. Col-
ony-escape mechanisms have been reported in epithelial 
cell colonies during epithelial cancer cell outgrowth where 
aberrant proliferation of these cells facilitates cancer cell 
progression [25]. Moreover, MDCK cells expressing onco-
genic Ras basally extrude from epithelial cell sheets [17].
the data presented here strongly suggest that PaK6 
plays a role in cell–cell dissociation in different colony-
forming cancer cell types. among the PaK family members 
tested, this phenotype is unique to PaK6 as depletion of 
PaK4 did not inhibit junction disassembly [47] and deple-
tion of PaK1/PaK2 did not result in the retention of pre-
dominant e-cadherin-positive junctions [6]. Interestingly, 
Mbt, a Drosophila PaK protein that shares close homol-
ogy with human group II PaKs, localizes at adherens junc-
tions when activated, and has been reported to induce the 
breakdown of these junctions during eye maturation [33]. 
In addition, the Xenopus PaK4 homologue, X-PaK5, also 
localizes at sites of cell contact and has been implicated in 
the cell–cell dissociation process [9]. We would speculate 
that in both of these instances the functionality could be 
related to PaK6 rather than other group II proteins.
Consistent with a role in junctional dynamics, we find 
PaK6 localized to cell–cell adhesions, and co-localized 
with e-cadherin and IQGaP1 at these regions. Stimula-
tion of cells with hGF leads to an increased association 
between IQGaP1 and PaK6, revealing that hGF modu-
lates the interaction. In our studies, we found that the 
C-terminal kinase domain of PaK6 independently inter-
acted with the N-terminal of IQGaP1, a region that binds 
to the kinase domain of the eGFR [32]. IQGaP1 modu-
lates the activation of the eGFR and subsequent signaling 
through this association [32]. We found that the presence 
of IQGaP1 increased the levels of PaK6 autophospho-
rylation but did not lead to phosphorylation of IQGaP1. 
this is consistent with a recent report that overexpression 
of IQGaP1 increases aurora-a phosphorylation levels 
[52]. however, the increased PaK6 autophosphorylation 
detected is unlikely to be focused on S560, as we found no 
evidence that co-expression of IQGaP1 and PaK6 modu-
lates phosphorylation levels at this specific site. Moreover, 
S560 levels downstream of hGF did not increase to a sig-
nificant level after 4-h hGF addition, when IQGaP1 and 
e-cadherin interactions with PaK6 are maximal.
PaK6, IQGaP1, and e-cadherin were found in complex 
downstream of hGF at a time point concomitant with cell–
cell dissociation. IQGaP1 also localizes at cell–cell junc-
tions in MCF-7 breast cancer cells [41] and the increased 
junctional localization of this protein correlates with a 
reduction in e-cadherin localization at sites of cell–cell 
contact in breast cancer cells [28]. Indeed, IQGaP1 has 
been shown to negatively modulate cell–cell adhesion in 
MDCK II colony-forming cells downstream of hGF [10]. 
however, the mechanism whereby IQGaP1 drives junc-
tion disassembly is not clearly elucidated. historically, 
IQGaP1 was thought to contribute to a reduction in cell–
cell adhesivity through its association with β-catenin [22]. 
It was proposed that this interaction with β-catenin induces 
α-catenin displacement from the e-cadherin-β-catenin 
complex in vitro and in vivo [22] and that removal of 
α-catenin weakens these adhesions [22, 35], thereby induc-
ing cell scattering [10]. Interestingly, studies have shown 
that α-catenin expression is lost from gastric, breast, and 
lung adenocarcinoma cells, cell types that also exhibit a 
scattered phenotype [34, 43].
Our data identify β-catenin as a novel substrate for 
human PaK6. the hyper-phosphorylation of β-catenin on 
serine/threonine residues has been shown to induce the loss 
of cell–cell junction sites from human epidermal cells [39], 
while a reduction in the phosphorylation of β-catenin pro-
motes cell–cell adhesion [23]. PaK1 [54] and PaK4 [27] 
are both reported to phosphorylate β-catenin at serine 675 
and we now find that the presence of PaK6 can also lead 
to increased levels of S675 phosphorylation. Moreover, our 
over-expression studies suggest that the phosphorylation 
status of β-catenin S675 correlates with a change in sub-
cellular localization where β-cateninwt is more likely to be 
found in the cell nucleus, consistent with previous findings 
[40], while a β-catenin mutant that cannot be phosphoryl-
ated at S675 (β-cateninS657a) is more likely to be held in the 
cell–cell junction region of the cell.
We propose that after hGF stimulation there is an opti-
mal interaction between e-cadherin, PaK6, and IQGaP1, 
which plays a role in driving cell–cell dissociation. Interac-
tion between PaK6 and IQGaP1 elevates PaK6 activity, 
which allows for β-catenin serine phosphorylation. these 
events could then trigger α-catenin dissociation from the 




anti-PaK4 (cross-reacts with PaK6) [47], anti-phospho-
PaK4/5/6 (S560), anti-PaK1, anti-PaK2, anti-IQGaP1, 
anti-eRK1/2, and anti-Cdc42 were obtained from Cell 
Signaling technology. anti-GaPDh was obtained from 
Millipore, anti-PaK6 from Calbiochem, anti-GFP from 
Roche, anti-RFP from Living Colors, Clontech, anti-e-
cadherin (heCD-1) from Genetex. anti-c-Myc (9e10), 
c-Met (C-12), anti-ha, and anti-Flag were obtained from 
Sigma-aldrich. Recombinant human hGF was purchased 
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from R&D Systems. Wt GSt-β-catenin was obtained 
from abcam. GFP-IQGaP1wt, GFP-IQGaP1 dominant 
negative, Myc-IQGaP1 N- and C-terminal mutants and 
GSt-IQGaP1717–863 are previously described [16, 37]. ha-
Cdc42v12 was a kind gift from Maddy Parsons, King’s Col-
lege London. GFP-β-cateninwt was a kind gift from Mark 
Dodding, King’s College London. Flag-β-cateninS675e 
and Flag-β-cateninS675a and Myc-PaK6wt, were a kind 
gift from Jonathan Chernoff, Fox Chase Cancer Center, 
Philadelphia, Pa, USa. the Gateway technology system 
(Invitrogen) was used to generate tagged PaK6 constructs 
Myc-PaK6wt was used as the DNa template in the produc-
tion of PaK6 DNa flanked by attB sequences; the addition 
of attB sequences is required for subsequent cloning into 
Gateway vectors. PaK6 DNa flanked by attB sequences 
was generated by PCR amplification using PaK6-spe-
cific primers: attB1 forward primer: 5′-GGGG aCa aGt 
ttG taC aaa aaa GCa GGC ttG atG ttC CGC 
aaG aaa aaG aaG aaa-3′. attB2 reverse primer: 5′-
GGGG a CCa Ctt tGt aCa aGa aaG CtG GGt C 
tCa GCa GGt GGa GGt CtG Ctt tCG-3′. the PCR 
products were used in Gateway recombination to generate 
entry clones that were sequenced prior to further recombi-
nation to generate expression vectors encoding GSt-PaK6 
[using pDeSt15 (Invitrogen)], GFP-PaK6wt, GFP-PaK6 
C-terminal mutant, RFP-PaK6 N- and C-terminal mutants 
and RFP-PaK6wt. the fidelity of these plasmids was sub-
sequently confirmed by sequencing. Plasmid peNtR-
PaK6 was used as a template for the mutagenic reactions. 
Clones were screened by sequencing and aligned to wild-
type sequences to confirm mutagenesis, prior to Gate-
way (Invitrogen) recombination to generate a expression 
vectors encoding GFP-PaK6S531N, GFP-PaK6S560e, and 
GFP-PaK6K436a.
Cell culture
DU145 cells (etCC) and Capan-1 cells (etCC) were 
grown in RPMI-1640 (Sigma), supplemented with 10 % 
FBS (helena Biosciences), l-glutamine, and 100 U/ml 
penicillin–streptomycin. In all cases, pre-plated cells were 
serum-starved for 24 h in low-serum media consisting of 
RPMI-1640 supplemented with 0.5 % FBS, l-glutamine, 
and 100 U/ml penicillin–streptomycin prior to hGF stim-
ulation. DU145 cells were transiently transfected using 
Fugene-6 hD transfection reagent according to the manu-
facturer’s protocol (Roche). heK293 (etCC) were grown 
in DMeM-GlutaMaX (Sigma) supplemented with 10 % 
FBS, l-glutamine, and 100 U/ml penicillin–streptomycin, 
and transfected by calcium-phosphate transfection accord-
ing to the manufacturer’s protocol (Invitrogen). ht29 cells 
(etCC) were grown in DMeM (Sigma) supplemented with 
10 % FBS, l-glutamine, and 100 U/ml penicillin–strepto-
mycin. ht29 cells were transiently transfected using Lipo-
fectamine 2000 according to the manufacturer’s protocol 
(Invitrogen).
Knockdown of PaK6 expression
PAK6 siRNa oligonucleotide 1 (Oligo 1) was purchased 
from ambion (austin, tX, USa). the sense sequence 
was 5′-GGCUaUUCCGaaGCaUGUUtt-3′. PAK6 
siRNa oligonucleotide (Oligo 2) was purchased from 
thermo Scientific Dharmacon, UK. the sense sequence 
was 5′-CCaaUGGGCUGGCUGCaaa-3′. Control-RNa 
oligonucleotide was purchased from Qiagen (cat. no. 
1022076). Control and PAK6-specific oligos were added 
to cells using hiPerFect transfection Reagent (Qiagen) 
according to the manufacturer’s instructions to a final con-
centration of 75 nM (Oligo 1) and 225 nM (Oligo 2).
Immunofluorescence and image analysis
Cells were fixed with 4 % PFa:PBS at room temperature 
for 20 min, washed three times with PBS, and permeabi-
lized with 0.2 % triton X-100/PBS for 5 min. Cells were 
then washed three times with PBS. For F-actin alone, cells 
were incubated at room temperature for 1 h with Phalloidin 
(Sigma). Coverslips were washed with PBS and mounted. 
For e-cadherin staining, cells were blocked in 3 % BSa-
PBS for 30 min, washed three times with PBS, and incu-
bated at room temperature for 2 h with anti-e-cadherin. 
Cells were then washed three times with PBS and incubated 
with anti-mouse secondary antibodies in addition to phal-
loidin. Coverslips were then washed and mounted. Images 
were collected on an Olympus IX71 inverted microscope, 
or a Carl Zeiss LSM510 Meta laser scanning confocal 
microscope. Images were processed in adobe Photoshop 
CS5. Cell area and elongation ratio [2] were quantified 
using ImageJ software (NIh).
Immunoprecipitation
Cells were lysed as previously described [45]. For immu-
noprecipitation experiments, cell lysates were pre-cleared 
with IgG coupled Protein a or G Sepharose beads (Ge 
healthcare) for 1 h at 4 °C. the pre-cleared lysates were 
then mixed with primary antibody overnight at 4 °C fol-
lowed by 1-h incubation with protein a or G-Sepharose 
beads. the immune complexes were washed three times 
with lysis buffer and resuspended in 2× SDS loading 
buffer. Proteins were resolved by SDS-PaGe as previously 
described [45]. autoradiographs were quantified using 
andor IQ software (andor, Belfast, UK).
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In vitro kinase assay
Kinases assays were performed as previously described [45]. 
Immune complexes were washed three times with lysis wash 
buffer, once with LiCl wash (0.5 M LiCl and 20 mM tris 
ph 8.0) and once with kinase wash buffer (50 mM tris–
hCl ph 7.5, 10 mM MgCl2, and 1 mM Dtt), then incu-
bated in kinase reaction buffer (2.5 mM hePeS ph7.4, 
50 mM Mgac, 0.5 mM atP, 40 mM MOPs, ph 7.0 and 
1 mM eDta) containing 1 μCi/μl of [γ-32P] atP together 
with histone h1 or recombinant GSt-β-catenin (Roche) for 
30 min at 30 °C. the reaction was stopped by adding SDS-
page loading buffer. autoradiographs and Western blots were 
quantified using andor IQ software (andor, Belfast, UK) 
and the level of phosphorylation normalized to protein levels.
GSt pulldown
GSt proteins were purified from BL21-a1 bacteria (Inv-
itrogen) as previously described [2]. Cells were lysed 
in NP-40 lysis buffer (0.5 % NP-40, 50 mM tris–hCl, 
ph 7.6, 30 mM sodium pyrophosphate, 150 mM NaCl, 
0.1 mM eDta, 50 mM NaF, 1 mM Na3VO4, 1 mM PMSF, 
10 μg/ml leupeptin, 1 μg/ml aprotinin, and 1 mM Dtt). 
Lysates were pre-cleared by incubation with GSt-coupled 
Glutathione Sepharose 4 Fast Flow beads (amersham) for 
1 h at 4 °C, then incubated with the GSt fusion protein 
beads for 2 h at 4 °C, collected by centrifugation, washed 
three times with lysis buffer, and resuspended in 2 × SDS 
loading buffer. Proteins were resolved by SDS-PaGe as 
previously described [45]. autoradiographs were quantified 
using andor IQ software (andor, Belfast, UK).
Acknowledgments this work was supported by Guys and St. 
thomas Charity (to CMW) the Medical Research Council (to SF) the 
Cancer and Polio Research Fund (to CMW) the Pancreatic Cancer 
Research Fund (to hK) and the Intramural Program of the National 
Institutes of health (to DBS).
Open Access this article is distributed under the terms of the Crea-
tive Commons attribution License which permits any use, distribu-
tion, and reproduction in any medium, provided the original author(s) 
and the source are credited.
References
 1. abo a, Qu J, Cammarano MS, Dan Ct, Fritsch a, Baud V, 
Belisle B, Minden a (1998) PaK4, a novel effector for Cdc42hs, 
is implicated in the reorganization of the actin cytoskeleton and 
in the formation of filopodia. eMBO J 17:6527–6540
 2. ahmed t, Shea K, Masters JR, Jones Ge, Wells CM (2008) a 
PaK4-LIMK1 pathway drives prostate cancer cell migration 
downstream of hGF. Cell Signal 20:1320–1328
 3. Baskaran Y, Ng YW, Selamat W, Ling Ft, Manser e (2012) 
Group I and II mammalian PaKs have different modes of activa-
tion by Cdc42. eMBO Rep 13:653–659
 4. Braga VMM, Betson M, Li XD, Lamarche-Vane N (2000) acti-
vation of the small GtPase Rac is sufficient to disrupt cadherin-
dependent cell–cell adhesion in normal human keratinocytes. 
Mol Biol Cell 11:3703–3721
 5. Briggs MW, Li ZG, Sacks DB (2002) IQGaP1-mediated stimula-
tion of transcriptional co-activation by beta-catenin is modulated 
by calmodulin. J Biol Chem 277:7453–7465
 6. Bright MD, Garner aP, Ridley aJ (2009) PaK1 and PaK2 have 
different roles in hGF-induced morphological responses. Cell 
Signal 21:1738–1747
 7. Chong C, tan L, Lim L, Manser e (2001) the mechanism of PaK 
activation—autophosphorylation events in both regulatory and 
kinase domains control activity. J Biol Chem 276:17347–17353
 8. de Leeuw WJF, Berx G, Vos CBJ, Peterse JL, Van de Vijver MJ, 
Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen a-M (1997) 
Simultaneous loss of e-cadherin and catenins in invasive lobular 
breast cancer and lobular carcinoma in situ. J Pathol 183:404–411
 9. Faure S, Cau J, Barbara PD, Bigou S, Ge QY, Delsert C, Morin 
N (2005) Xenopus p21-activated kinase 5 regulates blastomeres 
adhesive properties during convergent extension movements. Dev 
Biol 277:472–492
 10. Fukata M, Nakagawa M, Itoh N, Kawajiri a, Yamaga M, Kuroda 
S, Kaibuchi K (2001) Involvement of IQGaP1, an effector of 
Rac1 and Cdc42 GtPases, in cell–cell dissociation during cell 
scattering. Mol Cell Biol 21:2165–2183
 11. Gmyrek Ga, Walburg M, Webb CP, Yu hM, You XK, Vaughan 
eD, Woude GFV, Knudsen BS (2001) Normal and malignant 
prostate epithelial cells differ in their response to hepatocyte 
growth factor/scatter factor. am J Pathol 159:579–590
 12. Gumbiner B, Stevenson B, Grimaldi a (1988) the role of the cell 
adhesion molecule uvomorulin in the formation and maintenance 
of the epithelial junctional complex. J Cell Biol 107:1575–1587
 13. hage B, Meinel K, Baum I, Giehl K, Menke a (2009) Rac1 acti-
vation inhibits e-cadherin-mediated adherens junctions via bind-
ing to IQGaP1 in pancreatic carcinoma cells. Cell Commun Sig-
nal 7:23
 14. hart MJ, Callow MG, Souza B, Polakis P (1996) IQGaP1, a 
calmodulin-binding protein with a rasGaP-related domain, is a 
potential effector for cdc42hs. eMBO J 15:2997–3005
 15. herrenknecht K, Ozawa M, eckerskorn C, Lottspeich F, 
Lenter M, Kemler R (1991) the uvomorulin-anchorage pro-
tein alpha catenin is a vinculin homologue. Proc Natl acad Sci 
88:9156–9160
 16. ho YD, Joyal JL, Li ZG, Sacks DB (1999) IQGaP1 inte-
grates Ca2+/calmodulin and Cdc42 signaling. J Biol Chem 
274:464–470
 17. hogan C, Dupré-Crochet S, Norman M, Kajita M, Zimmermann 
C, Pelling ae, Piddini e, Baena-López La, Vincent JP, Itoh Y 
et al (2009) Characterization of the interface between normal and 
transformed epithelial cells. Nat Cell Biol 11:460
 18. Kaur R, Yuan X, Lu ML, Balk SP (2008) Increased PaK6 expres-
sion in prostate cancer and identification of PaK6-associated pro-
teins. Prostate 68:1510–1516
 19. Kaur R, Liu X, Gjoerup O, Zhang ah, Yuan X, Balk SP, Sch-
neider MC, Lu ML (2005) activation of p21-activated kinase 
6 by MaP kinase kinase 6 and p38 MaP kinase. J Biol Chem 
280:3323–3330
 20. Keely PJ, Westwick JK, Whitehead IP, Der CJ, Parise LV (1997) 
Cdc42 and Rac1 induce integrin-mediated cell motility and inva-
siveness through PI(3)K. Nature 390:632–636
 21. Kuroda S, Fukata M, Kobayashi K, Nakafuku M, Nomura N, 
Iwamatsu a, Kaibuchi K (1996) Identification of IQGaP as a 
putative target for the small GtPases, Cdc42 and Rac1. J Biol 
Chem 271:23363–23367
 22. Kuroda S, Fukata M, Nakagawa M, Fujii K, Nakamura t, 
Ookubo t, Izawa I, Nagase t, Nomura N, tani h et al (1998) 
2773PAK6 is required for cell–cell dissociation
1 3
Role of IQGaP1, a target of the small GtPases Cdc42 and Rac1, 
in regulation of e-cadherin-mediated cell–cell adhesion. Science 
281:832–835
 23. Lee Mh, Koria P, Qu J, andreadis St (2009) JNK phosphoryl-
ates beta-catenin and regulates adherens junctions. FaSeB J 
23:3874–3883
 24. Lee SR, Ramos SM, Ko a, Masiello D, Swanson KD, Lu ML, 
Balk SP (2002) aR and eR interaction with a p21-activated 
kinase (PaK6). Mol endocrinol 16:85–99
 25. Leung Ct, Brugge JS (2012) Outgrowth of single oncogene-
expressing cells from suppressive epithelial environments. Nature 
482:410–413
 26. Li Y, Shao Y, tong Y, Shen t, Zhang J, Gu h, Li F (2012) 
Nucleo-cytoplasmic shuttling of PaK4 modulates beta-catenin 
intracellular translocation and signaling. Biochim Biophys acta 
1823:465–475
 27. Li Y, Shao Y, tong Y, Shen t, Zhang J, Li Y, Gu h, Li F (2011) 
Nucleo-cytoplasmic shuttling of PaK4 modulates β-catenin 
intracellular translocation and signaling. Biochim Biophys acta 
1823:465–475
 28. Li ZG, Kim Sh, higgins JMG, Brenner MB, Sacks DB (1999) 
IQGaP1 and calmodulin modulate e-cadherin function. J Biol 
Chem 274:37885–37892
 29. Lozano e, Frasa MaM, Smolarczyk K, Knaus UG, Braga VMM 
(2008) PaK is required for the disruption of e-cadherin adhesion 
by the small GtPase Rac. J Cell Sci 121:933–938
 30. Manser e, huang hY, Loo th, Chen XQ, Dong JM, Leung t, 
Lim L (1997) expression of constitutively active alpha-PaK 
reveals effects of the kinase on actin and focal complexes. Mol 
Cell Biol 17:1129–1143
 31. Mataraza JM, Briggs MW, Li Z, Frank R, Sacks DB (2003) 
Identification and characterization of the Cdc42-binding site of 
IQGaP1. Biochem Biophys Res Commun 305:315–321
 32. McNulty De, Li ZG, White CD, Sacks DB, annan RS (2011) 
MaPK scaffold IQGaP1 binds the eGF receptor and modulates 
its activation. J Biol Chem 286:15010–15021
 33. Menzel N, Melzer J, Waschke J, Lenz C, Wecklein h, Lochnit 
G, Drenckhahn D, Raabe t (2008) the Drosophila p21-activated 
kinase Mbt modulates De-cadherin-mediated cell adhesion by 
phosphorylation of armadillo. Biochem J 416:231–241
 34. Ochiai a, akimoto S, Shimoyama Y, Nagafuchi a, tsukita S, 
hirohashi S (1994) Frequent loss of alpha-catenin expression in 
scirrhous carcinomas with scattered cell growth. Jpn J Cancer 
Res 85:266–273
 35. Ozawa M, Kemler R (1998) altered cell adhesion activity by 
pervanadate due to the dissociation of α-catenin from the e-cad-
herin–catenin complex. J Biol Chem 273:6166–6170
 36. Qu J, Cammarano MS, Shi Q, ha KC, De Lanerolle P, Minden 
a (2001) activated PaK4 regulates cell adhesion and anchorage-
independent growth. Mol Cell Biol 21:3523–3533
 37. Ren J-G, Li Z, Crimmins DL, Sacks DB (2005) Self-association 
of IQGaP1. J Biol Chem 280:34548–34557
 38. Schrantz N, Correia JD, Fowler B, Ge QY, Sun ZJ, Bokoch GM 
(2004) Mechanism of p21-activated kinase 6-mediated inhibition 
of androgen receptor signaling. J Biol Chem 279:1922–1931
 39. Serres M, Grangeasse C, haftek M, Durocher Y, Duclos B, 
Schmitt D (1997) hyperphosphorylation of beta-catenin on ser-
ine-threonine residues and loss of cell–cell contacts induced by 
calyculin a and okadaic acid in human epidermal cells. exp Cell 
Res 231:163–172
 40. Sun J, Khalid S, Rozakis-adcock M, Fantus IG, Jin t (2009) 
P-21-activated protein kinase-1 functions as a linker between 
insulin and Wnt signaling pathways in the intestine. Oncogene 
28:3132–3144
 41. Swart-Mataraza JM, Li ZG, Sacks DB (2002) IQGaP1 is a 
component of Cdc42 signaling to the cytoskeleton. J Biol Chem 
277:24753–24763
 42. thiery JP (2003) epithelial–mesenchymal transitions in develop-
ment and pathologies. Curr Opin Cell Biol 15:740–746
 43. Watabe M, Nagafuchi a, tsukita S, takeichi M (1994) Induc-
tion of polarized cell–cell association and retardation of growth 
by activation of the e-cadherin–catenin adhesion system in a dis-
persed carcinoma line. J Cell Biol 127:247–256
 44. Weissbach L, Settleman J, Kalady MF, Snijders aJ, Murthy ae, 
Yan YX, Bernards a (1994) Identification of a human RasGaP-
related protein containing calmodulin-binding motifs. J Biol 
Chem 269:20517–20521
 45. Wells CM, abo a, Ridley aJ (2002) PaK4 is activated via PI3 K 
in hGF-stimulated epithelial cells. J Cell Sci 115:3947–3956
 46. Wells CM, ahmed t, Masters JR, Jones Ge (2005) Rho family 
GtPases are activated during hGF-stimulated prostate cancer-
cell scattering. Cell Motil Cytoskelet 62:180–194
 47. Wells CM, Whale aD, Parsons M, Masters JR, Jones Ge (2010) 
PaK4: a pluripotent kinase that regulates prostate cancer cell 
adhesion. J Cell Sci 123:1663–1673
 48. Wen XQ, Li XJ, Liao B, Liu Y, Wu JY, Yuan XX, Ouyang B, Sun 
QP, Gao X (2009) Knockdown of p21-activated Kinase 6 inhibits 
prostate cancer growth and enhances chemosensitivity to Doc-
etaxel. Urology 73:1407–1411
 49. Whale a, hashim FN, Fram S, Jones Ge, Wells CM (2011) Sig-
nalling to cancer cell invasion through PaK family kinases. Front 
Biosci 16:849–864
 50. Yang F, Lio XY, Sharma MJ, Zarnegar M, Lim B, Sun Z (2001) 
androgen receptor specifically interacts with a novel p21-acti-
vated kinase, PaK6. J Biol Chem 276:15345–15353
 51. Yilmaz M, Christofori G (2009) eMt, the cytoskeleton, and can-
cer cell invasion. Cancer Metastasis Rev 28:15–33
 52. Yin N, Shi J, Wang D, tong t, Wang M, Fan F, Zhan Q (2012) 
IQGaP1 interacts with aurora-a and enhances its stability and 
its role in cancer. Biochem Biophys Res Commun 421(1):64–69
 53. Zeng Q, Lagunoff D, Masaracchia R, Goeckeler Z, Côté G, 
Wysolmerski R (2000) endothelial cell retraction is induced 
by PaK2 monophosphorylation of myosin II. J Cell Sci 
113:471–482
 54. Zhu G, Wang Y, huang B, Liang J, Ding Y, Xu a, Wu W (2011) 
a Rac1/PaK1 cascade controls β-catenin activation in colon can-
cer cells. Oncogene 31:1001–1012
